Phillip J. Koo, MD

Phillip J. Koo, MD

Banner MD Anderson Cancer Center

Phoenix, Arizona

Dr. Koo is the Division Chief of Diagnostic Imaging at the Banner MD Anderson Cancer Center in Arizona. Prior to this, he was Chief of Nuclear Medicine and Associate Professor of Radiology at the University of Colorado School of Medicine. Dr. Koo completed his transitional internship at the University of Pennsylvania Medical Center-Presbyterian, radiology residency at Pennsylvania Hospital of the University of Pennsylvania Health System, and fellowship at the Harvard Medical School Joint Program in Nuclear Medicine. He is a diplomate of both the American Board of Radiology (ABR) and American Board of Nuclear Medicine. Dr. Koo is an active member of multiple societies and serves on the scientific program committee for the Radiological Society of North America, nuclear radiology certifying exam committee for the ABR, and is the Chair of the Quality and Evidence Committee for the Society of Nuclear Medicine and Molecular Imaging. In 2015, he was the recipient of the Ursula Mary Kocemba-Slosky Award from the SNMMI/ERF. Dr. Koo has published on various topics related to radiology and nuclear medicine in multiple journals such as Radiology, Radiographics, European Journal of Nuclear Medicine and Molecular Imaging, Urology, and Journal of the American College of Radiology.

Articles by Phillip J. Koo, MD

Theranostics in Prostate Cancer

Phillip J. Koo, MD, Banner MD Anderson Cancer Center, Phoenix, Arizona discusses how theranostics will change the way physicians treat prostate cancer by helping select the appropriate patient for therapies and showing which ones respond. Keywords: prostate cancer, theranostics, nuclear medicine, therapeutics, diagnostic agent...

Read More

Osseous Metastatic Disease and Radium 223: Lessons Learned and Future Directions

This is presentation four of five of the CME accredited program, “The Multidisciplinary Approach to Treating Prostate Cancer Using Radiopharmaceuticals.” Please complete all lectures before completing the “CME Post-Test.”       Keywords: prostate cancer, radium-223, osseous metastatic disease How to cite: Koo, Phillip J. “Osseous Metastatic Disease and Radium 223: Lessons Learned and Future Directions.” Grand Rounds in Urology. November 6, 2016. Accessed Jan 2018. https://grandroundsinurology.com/prostate-cancer-phillip-koo-osseous-metastatic-disease-and-radium-223‎/. CME POST-TEST Thank you for participating in the CME activity. For CME credit, visit Medical College of Wisconsin. Immediately upon passing the online test, you will receive your certificate via email.   Transcript: Osseous Metastatic Disease and...

Read More

Accurate Staging of Prostate Cancer

Dr. Phillip J. Koo presented “Accurate Staging of Prostate Cancer.”at the 26th International Prostate Cancer Update on Thursday, January 21, 2016 Presentation      Keywords: prostrate cancer, choline, PSA, Prostascint, sodium fluoride, F-ACBC     How to cite: Koo, Phillip J. “Accurate Staging of Prostate Cancer.” Grand Rounds in Urology. January 21, 2016. Jan 2018 https://grandroundsinurology.com/accurate-staging-prostate-cancer.   Transcript Accurate Staging of Prostate Cancer It’s always a privilege to speak at this meeting, and over the years, I look back, and I’ve learned so much about prostate cancer, and I’ve learned so much about how what you guys have to do each day that has really...

Read More

Utility of NaF PET/CT and Other Diagnostic Radiopharmaceuticals in Prostate Cancer

Dr. Phillip J. Koo spoke at the 23rd annual Perspectives in Urology Point • Counterpoint meeting on Friday, November 14, 2014 on “Utility of NaF PET/CT and Other Diagnostic Radiopharmaceuticals in Prostate Cancer.”   Keywords: diagnostic radiopharmaceuticals, prostate cancer, NaF, PET/CT[/su_tab] How to cite: Koo, Phillip J. “Utility of NaF PET/CT and Other Diagnostic Radiopharmaceuticals in Prostate Cancer” Grand Rounds in Urology. July 21, 2015. Accessed Jan 2018. https://grandroundsinurology.com/prostate-cancer-phillip-j-koo-diagnostic-radiopharmaceuticals/. References Buchegger F, Garibotto V, Zilli T, et al. First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second...

Read More

Advances in PET Imaging

Dr. Phillip J. Koo spoke at the 24th International Prostate Cancer Update on Friday, February 21, 2014 on “Advance in PET Imaging.” In his presentation, Dr. Koo discusses advances in PET imaging and what the future holds. Presentation Keywords PET imaging, radiopharmaceuticals, FDG, choline, sodium fluoride How to cite: Koo, Phillip J. “Advances in PET Imaging.” Grand Rounds in Urology. January 14, 2015. Accessed [datetotoday]. https://grandroundsinurology.com/prostate-cancer-phillip-j-koo-pet-imaging/. Transcript Advances in PET Imaging So a warning, there’s a lot of confusion ahead, so I’ll try to keep it clear. Disclosures—I participated in a reader study for approval of a new radiopharmaceutical in...

Read More

Join the GRU Community

- Why Join? -